Fulcrum Therapeutics Inc (FULC) — Cash Flow Reinvestment Rate
Latest as of June 2024:
0.21x
Fulcrum Therapeutics Inc (FULC) has a Cash Flow Reinvestment Rate of 0.21x as of June 2024, reinvesting $12.51 Million (capex $0.00 plus investments $-12.51 Million) from operating cash flow of $58.90 Million. See cash generation quality of Fulcrum Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.21x
(Capex + Investments) / Operating CF
Total Reinvested
$12.51 Million
Capex + Investments
Operating Cash Flow
$58.90 Million
USD
Capital Expenditures
$0.00
USD
Annual Cash Flow Reinvestment Rate for Fulcrum Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Fulcrum Therapeutics Inc. See FULC financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow